Paclitaxel selectively induces mitotic arrest and apoptosis in proliferating bovine synoviocytes

Arthritis and Rheumatism

Volumn 40, Issue 6, 1997, Pages 1073-1084

  Hui, A ^a   Kulkarni, G V ^b   Hunter, W L ^c   McCulloch, C A G ^b   Cruz, T F ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c Angiogenesis Technologies Inc   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE G2 PHASE; CELL PROLIFERATION; CELL SYNCHRONIZATION; CYTOSKELETON; INFLAMMATORY CELL; LYMPHOCYTIC INFILTRATION; MITOSIS RATE; NONHUMAN; PANNUS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; SYNOVIUM;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CATTLE; CELL ADHESION; CELL COMMUNICATION; CELL DIVISION; CELL SURVIVAL; CELLS, CULTURED; INTERPHASE; MITOSIS; PACLITAXEL; S PHASE; SYNOVIAL MEMBRANE;

EID: 0030905236     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780400612     Document Type: Article

References (41)

1. Tranbandt A, Gay RE, Gay S: Oncogene activation in rheumatoid synovium. APMIS 100:861-875, 1992
2. Zvaifler NJ: Rheumatoid arthritis. LabInvest 73:307-310, 1995
3. Trentham DE, Townes AS, Kang AH: Autoimmunity to type II collagen: an experimental model of arthritis. J Exp Med 146:857-868, 1977
4. Fassbender HG: Histomorphologic basis of articular cartilage destrction in rheumatoid arthritis. Coll Relat Res 3:141-155, 1983
5. Harris ED Jr: Recent insights into the pathogenesis of the proliferative lesion in rheumatoid arthritis. Arthritis Rheum 19:68-72, 1976
6. O'Sullivan FX, Fassbender H-G, Gay S, Koopman WJ: Etiopatho-genesis of the rheumatoid arthritis-like disease in MRL/1 mice. I. The histomorphologic basis of joint destruction. Arthritis Rheum 28:529-536,1985
7. Tanaka A, O'Sullivan FX, Koopman WJ Gay S: Etiophathogenesis of the rheumatoid arthritis like disease in MRL/1 mice. II. Ultrastructural basis of joint destruction. J Rheumatol 15:10-16, 1988
8. Hamilton JA: Hypothesis: in vitro evidence for the invasive and tumour-like properties of the rheumatoid pannus. J Rheumatol 10:845-851,1983
9. Wani MC, Taylor HL, Wall ME, Coggon P, McPhail AT: Plant antitumor agents.VI. The isolation and structure of Taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chemical Soc 93:2325-2327, 1971
10. Wiernik PH, Schwartz EL, Strauman JJ, Dutcher JP, Lipton BR, Paietta E: Phase I clinical and pharmacokinetic study of paclitaxel. Cancer Res 47:2486-2493, 1987
11. Horwitz SB: Mechanism of action of Taxol, Trends Pharmacol Sci 13:134-136, 1992
12. Arnal I, Wade RH: How does Taxol stabilize microtubules? Curr Biol 5:900-908, 1995
13. Nogales E, Wolf SG, Khan IA, Luduena RF, Downing KH: Structure of tubulin at 6.5A and location of the Taxol-binding site. Nature 375:424-427, 1995
14. Schiff PB, Horwitz SB: Taxol stabilizes microtubules in mouse fibroblast cells. Proc Natl Acad Sci U S A 77:1561-1565, 1980
15. Ireland CM, Pittman SM: Tubulin alterations in Tuxol-induced apoptosis parallel those observed with other drugs. Biochem Pharmacol. 49:1491-1499, 1995
16. Danesi R, Figg WD, Reed E, Myers CE: Paclitaxel (Taxol) inhibits isoprenylation and induces apoptosis in PC-3 prostate cancer cells. Mol Pharmcol 47:1106-1111: 1995
17. Donaldson KL, Goolsby G, Kiener PA, Wahl AF: Activation of p34cdc2 coincident with Taxol-induced apoptosis. Cell Growth Differ 5:1041-1050, 1994
18. Bhalla K, Ibrado AM, Tourkina E, Tang C, Mahoney ME, Huang Y: Paclitaxel induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells. Leukemia 7:563-568,1993
19. Brahn E, Tang C, Banquerigo ML: Regression of collagen-induced arthritis with Taxol, a microtubule stabilizer. Arthritis Rheum 37:839-845, 1994
20. Howarth D, Pritzker KPH, Cruz TF, Kandel RA: Calcium ionophore A23187 stimulates the production of a 144 kDa gelatinase. J Rheumatol. 20:97-101, 1993
21. Cruz TF, Mills G, Pritzker PH Kandel AK: Inverse correlation between tyrosine phosphorylation and collagenase production in chrondrocytes. J Biochem 269:717-721,1990
22. Kulkarni GV, McCulloch CAG: Serum deprivation induces apoptotic cell death in a subset of Balb/c 3T3 fibroblasts, J Cell Sci 107:1169-1179, 1994
23. Telford WG, King LE, Fraker PJ: Comparative evaluation of several DNA binding dyes in the detection of apoptosis-associated chromatin degradation of by flow cytometry. Cytometry 13:137-143, 1992
24. Gazitt Y, Grodos GW: Fluctuations and ultrastructural localization of oncoproteins and cell cycle regulatory proteins during growth and apoptosis of synchronized AGF cells. Cancer Res 54:950-956, 1994
25. Zvaifler NJ, Firestein GS: Pannus and pannoeytes: alternative models of joint destruction in rheumatoid arthritis. Arthritis Rheum 37:783-789, 1994
26. Schumacher HR Jr: In, Rheumatoid Arthritis. Edited by HR Schumacher Jr, EP Gall. Philadelphia, JB Lippincott, 1988
27. Mohr W, Hummler N, Pelster B, Wessinghage D: Proliferation of pannus tissue cells in rheumatoid arthritis. Rheumatol Int 6:127-132, 1986
28. Nicolaou KC, Riemer C Kerr MA, Rideout D, Wrasidlo W: Design, synthesis and biological activity of protaxols. Nature 364:464-466, 1993
29. Matsuoka H, Furusawaa M, Tomodaa H, Seo Y: Difference in cytotoxicity of paclitaxel against neoplastic and normal cells. Anticancer Res 14:163-168, 1994
30. Darzynkiewicz Z, Bruno SG Del Bino G, Grocxyca W, Hotz MA, Lassota P, Traganos F: Features of apoptotic cells measured by flow cytometry. Cytometry 13:795-808: 1992
31. Gorczyca W, Gong J, Darzynkiewicz Z: Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick traslation assays. Cancer Res 53:1945-1951, 1993
32. Oberhammer F, Wilson JW, Dive C, Morris ID, Hickman JA, Wakeling AE, Walker PR, Sikorska M: Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J 12:3679-3684, 1993
33. Tomei LD, Shapiro JP, Cope FO: Apoptosis in C3H/10T mouse embryonic cells: evidence for internucleosomal DNA modification in the absence of double-strand cleavage. Proc Natl Acad Sci U S A 90:853-857, 1993
34. Fournel S, Genestier L, Rouasult JP, Lizard G, Flacher M, Assossou O, Revillard JP: Apoptosis without decrease of cell DNA content. FEBS Lett 367:188-192, 1995
35. Cohen GM, Sun XM, Snowden RT, Dinsdale D, Skilleter DN. Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. J Biochem 286:331-334, 1992
36. Firestein GS, Yeo M, Zvaifler NJ: Apoptosis in rheumatoid arthritis synovium. J Clin Invest 96:1631-1638, 1995
37. Rowinsky EK, Donehower RC, Jones RJ, Tucker RW: Microtubule changes and cytotoxicity in leukemic cell lines treated with taxol. Cancer Res 48:4093-4100, 1988
38. Robert JR, Allison DC, Donehower RC, Rowinsky EK: Development of polyploidization in Taxol resistant human leukemia cells in vitro. Cancer Res 50:710-716, 1990
39. Stenman S, Wartiovaara J, Vaheri A: Changes in the distribution of a major fibroblast protein, fibronectin, during mitosis and interphase. J Cell Biol 74:453-467, 1977
40. Evan GI, Brown L, Whyte M, Harrington E: Apoptosis and cell cycle. Curr Biol 7:825-834, 1995
41. Martin SJ, Green DR: Protease activation during apoptosis: death by a thousand cuts? Cell 82:349-352, 1995